Press Release

Eden Radioisotopes, LLC and Sandia National Laboratories Earn 2019 Technology Transfer Award From the Federal Laboratory Consortium, Mid-Continent Region

ALBUQUERQUE, N.M., November 21, 2019 (Newswire.com) –​Eden Radioisotopes, LLC, an Albuquerque, NM, startup company, and Sandia National Laboratories earned a regional Federal Laboratory Consortium (FLC) award recognizing federal laboratories and their partners for outstanding work to develop and commercialize innovative technologies. The FLC, Mid-Continent Region recognized the Sandia–Eden partnership nomination, Small Reactor to Help Solve Worldwide […]

Eden Radioisotopes, LLC and Sandia National Laboratories Earn 2019 Technology Transfer Award From the Federal Laboratory Consortium, Mid-Continent Region Read More »

Eden Radioisotopes, LLC, Secures Reactor Project Funding for Medical Isotope Production

ALBUQUERQUE, N.M., May 22, 2019 (Newswire.com) –​​​Eden Radioisotopes, LLC, an Albuquerque, NM startup company, is pleased to announce an investment agreement with Abo Empire, LLC, a Yates Family company. This investment funds the company project to build a reactor of less than 2MW in New Mexico for the purpose of producing medical isotopes, primarily Molybdenum-99. Known

Eden Radioisotopes, LLC, Secures Reactor Project Funding for Medical Isotope Production Read More »

Moly 99 reactor using Sandia design could lead to U.S. supply of isotope to track disease

ALBUQUERQUE, N.M. — An Albuquerque startup company has licensed a Sandia National Laboratories technology that offers a way to make molybdenum-99, a key radioactive isotope needed for diagnostic imaging in nuclear medicine, in the United States. Known as moly 99, it is made in aging nuclear reactors outside the country, and concerns about future shortages

Moly 99 reactor using Sandia design could lead to U.S. supply of isotope to track disease Read More »